Halo Pharma Enhances Manufacturing Capabilities with Macro-Pactor® Investment

New addition enhances manufacturing continuity and supports seamless progression from early-phase development to late-stage ...
FiercePharma

Novartis presses court for hasty decision in long-running Entresto patent feud with MSN

In its continued bid to waylay the launch of MSN Pharmaceuticals’ proposed Entresto generic, Novartis has told a federal judge in Delaware that time is of the essence. Novartis has submitted a request ...
Morningstar

New ixlayer Survey Finds 73% of Pharma Leaders Are Running or Planning to Launch a DTP Program in the Next Year, and Half Say DTP Will Be Standard Practice Within Five Years

94% of pharma are either running (43%), planning to launch in the next twelve months (30%) or exploring (21%) a DTP program Only 6% have no current plans for a DTP program The number one potential ...
News Medical

Optimizing Pharmaceutical Operations: 4 Main Advantages of Preventative Maintenance

With the interlinking and complex aspects of the drug pipeline, routine processes can, however, be easily overlooked. One frequently neglected area is preventative maintenance. Embracing a ...